Jeffrey Newman
Geriatric Medicine · Bonsall, CANPI 1922082189
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,044 and has fallen 94.1% since, to $120 in 2025.
Across 181 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$635
- AbbVie$345
- Vanda Pharmaceuticals Inc.$333
- Sanofi-aventis U.S. LLC$223
- GSK$215
- Lilly USA, LLC$213
- plus $2K from 32 others
What the payments were for
- Consulting fees$170%
- Food & beverage$3,451100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $635 |
| AbbVie | 26 | $345 |
| Vanda Pharmaceuticals Inc. | 13 | $333 |
| Sanofi-aventis U.S. LLC | 17 | $223 |
| GSK | 14 | $215 |
| Lilly USA, LLC | 7 | $213 |
| Mylan Specialty L.p. | 7 | $157 |
| Amarin Pharma, Inc. | 9 | $146 |
| Kowa Pharmaceuticals America, Inc. | 8 | $134 |
| Pfizer | 6 | $111 |
| Topcon Healthcare Solutions, Inc. | 2 | $98 |
| Atricure, Inc. | 1 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $87 |
| Scilex Pharmaceuticals Inc. | 4 | $74 |
| Eisai Inc. | 5 | $71 |
| Astellas Pharma US Inc | 3 | $56 |
| Novo Nordisk | 3 | $47 |
| Gilead | 3 | $46 |
| Alkermes, Inc. | 2 | $40 |
| Amgen | 2 | $34 |
| Abbott | 2 | $27 |
| IBSA Pharma Inc. | 1 | $23 |
| Vertiflex, Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $20 |
| Neotract Inc. | 1 | $19 |
| Kaleo, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| Indivior Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Merck | 1 | $15 |
| SK Life Science, Inc. | 1 | $12 |
| Nevro Corp. | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$338
- SYMBICORT$338
- BREZTRI AEROSPHERE$180
- MOVANTIK$157
- KISUNLA$120
How this compares
$3,468 in reported general payments places this provider in the 85th percentile of 494 geriatric medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $2,763 |
| Levothyroxine Sodium | 45 | $652 |
| Tamsulosin Hcl | 20 | $601 |
| Oxybutynin Chloride | 18 | $395 |
| Omeprazole | 28 | $389 |
| Atorvastatin Calcium | 16 | $363 |
| Lisinopril | 21 | $254 |
| Metformin Hcl | 18 | $217 |
| Spironolactone | 16 | $172 |
| Potassium Chloride | 11 | $128 |
| Escitalopram Oxalate | 11 | $122 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Bonsall
- Robert FeldmanLaguna Hills$1.2M
- Oscar ChienSan Gabriel$208K
- Anders NybergSan Diego$160K
- Paul AisenSan Diego$70K
- Wayne ChenLos Angeles$40K
- Vincent HoLancaster$32K
- Kathryn SewellSan Francisco$26K
- Stephen HenryPasadena$25K
- Chaewon SongGarden Grove$21K
- Douglas ZhangSan Leandro$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.